当前位置: X-MOL 学术Trends Endocrin. Met. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Taking Aim at Glycolysis with CDK8 Inhibitors
Trends in Endocrinology & Metabolism ( IF 10.9 ) Pub Date : 2018-05-01 , DOI: 10.1016/j.tem.2018.02.005
Robert P. Fisher

Dependence on glycolysis under aerobic conditions, a frequent metabolic derangement in cancer cells, suggests a therapeutic opportunity. Now, through chemical genetics, CDK8, a kinase associated with the Mediator transcriptional coactivator complex, has emerged as an upstream inducer of glycolysis and a possible target for anticancer drug discovery.

中文翻译:

用 CDK8 抑制剂瞄准糖酵解

有氧条件下对糖酵解的依赖,癌细胞中常见的代谢紊乱,表明了治疗机会。现在,通过化学遗传学,CDK8(一种与 Mediator 转录共激活因子复合物相关的激酶)已成为糖酵解的上游诱导剂和抗癌药物发现的可能靶点。
更新日期:2018-05-01
down
wechat
bug